Lakewood-Amedex Biotherapeutics, Inc.
Lakewood-Amedex Biotherapeutics, Inc. (LABT) — Form 424B3: Prospectus
About this filing
Lakewood-Amedex Biotherapeutics, Inc. (LABT) filed Form 424B3 (prospectus) with the SEC on Aug 17, 2026.
Key facts
- Document
- PROSPECTUS SUPPLEMENT
More LABT filings
- 8-K
Filed Sep 28, 2026
- EFFECT
Filed Sep 24, 2026
- S-1
Filed Sep 18, 2026
- DRS
Filed Aug 21, 2026
- SC 13G
Filed Aug 14, 2026
- 10-Q
Filed Aug 13, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.